Big pharma turns to wearables to track participants in clinical trials
Add BT as a preferred sourceWashington
PHARMACEUTICAL companies are enlisting Fitbits and other gadgets strapped to patients' wrists, chests and skin as a way to bring drugs to market faster.
What began as an aid for athletes and dieters to track their movements is quickly becoming a critical tool for medical researchers and drugmakers. By outfitting trial participants with wearables, companies are starting to amass precise information and gather round-the-clock data in hopes of streamlining trials and better understanding whether a drug is working.
TRENDING NOW
How BYD disrupted Singapore’s car market – and why the strategy is turning on itself
Vietnam seeks US$76 billion a year from capital markets to ease reliance on banks
Too little, too late? Manila’s billion-dollar bid to ignite its sputtering EV industry
Two-thirds of Sentosa Cove resales in the red, with average loss topping S$1 million since 2023
